(Q37990399)

26 August 2017

title

Radiopharmaceutical development of radiolabelled peptides (English)

1 reference

26 August 2017

Melpomeni Fani

1

1 reference

26 August 2017

Helmut R Maecke

series ordinal

2

1 reference

26 August 2017

publication date

1 February 2012

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

26 August 2017

published in

1 reference

26 August 2017

volume

39 Suppl 1

1 reference

26 August 2017

page(s)

S11-30

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-011-2001-z

26 August 2017

exact match

0 references

cites work

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

(18)F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

In vivo positron emission tomography (PET) imaging with an alphavbeta6 specific peptide radiolabeled using 18F-"click" chemistry: evaluation and comparison with the corresponding 4-[18F]fluorobenzoyl- and 2-[18F]fluoropropionyl-peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

"Click labeling" with 2-[18f]fluoroethylazide for positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

A novel facile method of labeling octreotide with (18)F-fluorine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Imaging of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Targeted radiotherapy with radiolabeled somatostatin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Design, synthesis, and biological evaluation of somatostatin-based radiopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

First clinical evidence that imaging with somatostatin receptor antagonists is feasible

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Glucagon-like peptide 1-receptor scans to localize occult insulinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Glucagon-like peptide-1 receptor imaging for localization of insulinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Positron emission tomography tracers for imaging angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2001-Z

Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting

21 January 2018

1 reference

12 December 2020

N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination

1 reference

12 December 2020

Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692

1 reference

12 December 2020

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

1 reference

12 December 2020

A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling

1 reference

12 December 2020

Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors

1 reference

12 December 2020

CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.

1 reference

12 December 2020

Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment

1 reference

12 December 2020

Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F

1 reference

12 December 2020

Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo

1 reference

12 December 2020

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

1 reference

12 December 2020

GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle

1 reference

12 December 2020

NC-100717: a versatile RGD peptide scaffold for angiogenesis imaging

1 reference

12 December 2020

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

1 reference

12 December 2020

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors

1 reference

12 December 2020

New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.

1 reference

12 December 2020

G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family.

1 reference

12 December 2020

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

1 reference

12 December 2020

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

1 reference

12 December 2020

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

1 reference

12 December 2020

Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study

1 reference

12 December 2020

Bombesin receptor antagonists may be preferable to agonists for tumor targeting

1 reference

12 December 2020

Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64

1 reference

12 December 2020

Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor

1 reference

12 December 2020

177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.

1 reference

12 December 2020

Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy.

1 reference

12 December 2020

GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog

1 reference

12 December 2020

Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist

1 reference

12 December 2020

Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide

1 reference

12 December 2020

18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

1 reference

12 December 2020

10.1007/S00259-011-2001-Z

Identifiers

DOI

1 reference

26 August 2017

1 reference